Plunkett Research Online: Adamas Pharmaceuticals

ADAMAS PHARMACEUTICALS (ADMS:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Adamas Pharmaceuticals Inc is primarily focused on the development and commercialization of therapeutics targeting chronic disorders of the central nervous systems. The company has an approved product called GOCOVRI for a complication associated with the treatment of Parkinson's disease known as lev.....



Adamas Pharmaceuticals
Ticker: ADMS
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 510 450-3500
Fax: 510 428-0519
Address: 1900 Powell Street
Suite 750
Emeryville, CA 94608 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing
ContactsDescription
Alfred MerriweatherCFO
Christopher PrentissChief Accounting Officer
See More
Adamas Pharmaceuticals Inc is primarily focused on the development and commercialization of therapeutics targeting chronic disorders of the central nervous systems. The company has an approved product called GOCOVRI for a complication associated with the treatment of Parkinson's disease known as lev.....See More See More

Auditor: PricewaterhouseCoopers LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: